CA 15-3 may be useful in monitoring response to therapy in patients with metastatic breast cancer. A majority of patients with a CA 15-3 increase of greater than 25% have disease progression.
The comprehensive metabolic panel (CMP) is a frequently ordered panel of 14 tests that gives a healthcare provider important information about the current status of a person’s metabolism, including the health of the kidneys and liver, electrolyte and acid/base balance as well as levels of blood glucose and blood proteins.
Components: Glucose BUN Creatinine Sodium Potassium Chloride CO2 Calcium Total Protein Albumin Total Bilirubin Alk. Phos. AST ALT GFR
Useful for the evaluation of hypogonadism and oligoamenorrhea in females. Also used for monitoring low-dose female hormone replacement therapy in postmenopausal women
This test is a tumor marker that is useful in the management of patients with metastatic carcinoma of the breast.